Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ziarco Pharma Ltd.

www.ziarcopharma.com

Latest From Ritter Pharmaceuticals Inc.

Pipeline Watch: Phase III Starts In PTSD, Alzheimer’s Disease And Pancreatic Cancer

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch Approvals

Deals Shaping The Medical Industry, November 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in October 2016.

Deals Market Intelligence

Execs On The Move, December 2015

Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

BioPharmaceutical Medical Device

Mining The Microbiome: Are Gut Microbes The Next Big Source Of Drugs?

There is growing interest in the gut microbiome as a source of new therapies across a wide range of diseases. Although it is still an emerging field, pharmaceutical firms and other investors are engaging, with more expected to follow.

BioPharmaceutical
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Topical Delivery
  • Therapeutic Areas
  • Dermatology
  • Immune Disorders
  • Inflammation
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Ziarco Pharma Ltd.
  • Senior Management
  • Lynn Purkins, PhD, Chief Dev. Officer
    Wai (Steve) Liu, PhD, CSO
    Pablo Jimenez, MD, CMO
    Arvind Hundal, CBO
  • Contact Info
  • Ziarco Pharma Ltd.
    Phone: 01304 806889
    Innovation House/Discovery Pk/Office 49
    Ramsgate Rd.
    Sandwich , CT13 9ND
    UK
Advertisement
Advertisement
UsernamePublicRestriction

Register